Delivery Order SPE2DB20D3505-SPE2DB25FV1J5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-unit quantities, valued at $1,068.57. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for ultimate completion by July 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for Cyclosporine 0.05% Eye Emulsion in 30-unit quantities, with a ceiling value of $3,975.87. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement through open competition. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,307.00 to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (60 single-use containers) on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's larger prime contract vehicle. The pharmaceutical will be delivered to the company's distribution facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for Cyclosporine 0.05% Eye Emulsion in 30-count units, valued at $1,215.91. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by September 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $7,327.31 delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (30-count packages) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction under the company's broader federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-count units, with a ceiling value of $1,091.41. This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $10,114.72 delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (30 count) on September 15, 2025, with a completion date of September 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $1,216.72 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 60-unit packaging. This is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, utilizing no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs. The...
- The Defense Logistics Agency awarded a $8,041.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (60 count). This is a non-set-aside competitive award with an ultimate completion date of September 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in Conshohocken, PA. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,625.76 to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-count units. This is a firm fixed-price, non-set-aside contract with performance to be completed by July 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FV1J5Delivery Order
The Defense Logistics Agency awarded a $1,872.12 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for Cyclosporine 0.05% Eye Emulsion (30 units). This is a firm fixed price, competitively awarded contract with no set-aside designation, with performance at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is scheduled for completion by August 7, 2025, reflecting the expedited nature of pharmaceutical supply fulfillment to support federal medical needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare systems, AmerisourceBergen Drug Corp maintains a comprehensive portfolio supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/6/25 |